Who owns Mereo Biopharma Group Plc ads?
- Ticker: MREO
- CUSIP Number: 589492107
Tip: Access positions for across all investors
Analyze quarterly positions in Mereo Biopharma Group Plc ads with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mereo Biopharma Group Plc ads stock
Who bought or sold Mereo Biopharma Group Plc ads this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Henderson Group | 17M | $60M | 39% | Dec 2024 |
|
| Rubric Capital Management | 15M | $54M | 0% | Dec 2024 |
|
| Rock Springs Capital Management | 9.6M | $34M | 1% | Dec 2024 |
|
| Adage Capital Partners GP | 8.7M | $31M | -10% | Dec 2024 |
|
| Mangrove Partners | 8.6M | $30M | -1% | Dec 2024 |
|
| Deerfield Management Company | 6.7M | $24M | 0% | Dec 2024 |
|
| Frazier Life Sciences Management | 5.1M | $18M | 0% | Dec 2024 |
|
| Alkeon Capital Management | 4.7M | $16M | 0% | Dec 2024 |
|
| 683 Capital Management | 4.6M | $16M | -6% | Dec 2024 |
|
| Millennium Management | 4.0M | $14M | -26% | Dec 2024 |
|
| Morgan Stanley | 3.6M | $14M | 51% | Dec 2024 |
|
| Clearline Capital | 3.2M | $11M | -1% | Dec 2024 |
|
| UBS Group | 2.6M | $9.3M | 100% | Dec 2024 |
|
| Tejara Capital | 2.3M | $8.1M | -18% | Dec 2024 |
|
| Goldman Sachs Group | 2.1M | $7.4M | 6% | Dec 2024 |
|
| Renaissance Technologies | 1.2M | $4.2M | -9% | Dec 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.2M | $4.0M | 100% | Dec 2024 |
|
| Perceptive Advisors | 1.1M | $3.8M | 33% | Dec 2024 |
|
| Integral Health Asset Management | 1.0M | $3.5M | 0% | Dec 2024 |
|
| Ubs Global Asset Management Americas | 965k | $3.4M | 100% | Dec 2024 |
|
| Tema Etfs | 891k | $3.1M | 100% | Dec 2024 |
|
| Marshall Wace | 866k | $3.0M | -16% | Dec 2024 |
|
| NEOS Investment Management | 825k | $2.9M | -1% | Dec 2024 |
|
| Soleus Capital Management | 787k | $2.8M | -7% | Dec 2024 |
|
| Longwood Capital Partners | 779k | $2.7M | -38% | Dec 2024 |
|
| Eversept Partners | 778k | $2.7M | 0% | Dec 2024 |
|
| Blue Owl Capital Holdings | 673k | $2.4M | -21% | Dec 2024 |
|
| Woodline Partners | 619k | $2.2M | 100% | Dec 2024 |
|
| Susquehanna International | 550k | $1.9M | -25% | Dec 2024 |
|
| Citadel Advisors | 495k | $1.7M | 90% | Dec 2024 |
|
| Schonfeld Strategic Advisors | 494k | $1.7M | 100% | Dec 2024 |
|
| Artia Global Partners | 421k | $1.5M | 0% | Dec 2024 |
|
| HealthInvest Partners AB | 390k | $1.4M | 95% | Dec 2024 |
|
| Monaco Asset Management SAM | 382k | $1.3M | -1% | Dec 2024 |
|
| Knott David M Jr | 331k | $1.2M | 0% | Dec 2024 |
|
| Jane Street | 329k | $1.2M | -22% | Dec 2024 |
|
| Hudson Bay Capital Management | 315k | $1.1M | 80% | Dec 2024 |
|
| BlackRock | 273k | $956k | 1806% | Dec 2024 |
|
| Knoll Capital Management | 261k | $912k | 0% | Dec 2024 |
|
| Verition Fund Management | 238k | $832k | 116% | Dec 2024 |
|
| Cantor Fitzgerald, L. P. | 225k | $788k | 100% | Dec 2024 |
|
| Polar Securities | 170k | $595k | -14% | Dec 2024 |
|
| Walleye Trading Advisors | 130k | $454k | 100% | Dec 2024 |
|
| Ameriprise Financial | 95k | $331k | 188% | Dec 2024 |
|
| Geode Capital Management | 92k | $323k | 0% | Dec 2024 |
|
| J. Goldman & Co | 90k | $314k | -65% | Dec 2024 |
|
| Two Sigma Investments | 69k | $241k | -49% | Dec 2024 |
|
| Simplex Trading | 55k | $192k | 63% | Dec 2024 |
|
| State Street Corporation | 47k | $165k | -1% | Dec 2024 |
|
| Clear Harbor Asset Management | 42k | $147k | -3% | Dec 2024 |
|
| PFG Investments | 39k | $138k | 132% | Dec 2024 |
|
| XTX Topco | 38k | $133k | 100% | Dec 2024 |
|
| Forefront Analytics | 35k | $122k | 3% | Dec 2024 |
|
| Avanza Fonder AB | 28k | $67k | 43% | Mar 2025 |
|
| Centiva Capital | 25k | $88k | 0% | Dec 2024 |
|
| Squarepoint Ops | 24k | $83k | 14% | Dec 2024 |
|
| Golden State Equity Partners | 23k | $79k | 248% | Dec 2024 |
|
| Graham Capital Management | 22k | $78k | 75% | Dec 2024 |
|
| Virtus ETF Advisers | 19k | $67k | 100% | Dec 2024 |
|
| Resources Investment Advisors | 18k | $64k | 0% | Dec 2024 |
|
| Sheets Smith Investment Management | 17k | $59k | 100% | Dec 2024 |
|
| Manufacturers Life Insurance Company | 16k | $58k | 11% | Dec 2024 |
|
| Hsbc Holdings | 14k | $48k | -52% | Dec 2024 |
|
| Jump Financial | 11k | $39k | 100% | Dec 2024 |
|
| Significant Wealth Partners | 11k | $38k | 100% | Dec 2024 |
|
| Newbridge Financial Services Group | 11k | $38k | 100% | Dec 2024 |
|
| Level Four Advisory Services | 10k | $35k | 0% | Dec 2024 |
|
| ADAR1 Capital Management | 10k | $35k | 0% | Dec 2024 |
|
| GAMMA Investing | 8.4k | $19k | -7% | Mar 2025 |
|
| Rhumbline Advisers | 6.6k | $15k | -9% | Mar 2025 |
|
| SRS Capital Advisors | 4.0k | $14k | 0% | Dec 2024 |
|
| Bank of America Corporation | 2.3k | $8.1k | -99% | Dec 2024 |
|
| Lindbrook Capital | 1.7k | $5.8k | 0% | Dec 2024 |
|
| GPS Wealth Strategies Group | 1.5k | $3.4k | 0% | Mar 2025 |
|
| Hanson McClain Advisors | 1.5k | $4.4k | 0% | Dec 2024 |
|
| BFSG | 1.0k | $3.5k | 0% | Dec 2024 |
|
| Sit Investment Associates | 970.00 | $3.0k | 0% | Dec 2024 |
|
| Signature | 679.00 | $2.4k | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 365.00 | $1.3k | 0% | Dec 2024 |
|
| MAI Wealth Advisors | 309.00 | $1.1k | 100% | Dec 2024 |
|
| New England Capital Financial Advisors | 300.00 | $1.1k | 0% | Dec 2024 |
|
| Wells Fargo & Company | 229.00 | $802.003800 | 0% | Dec 2024 |
|
| GeoWealth Management | 158.00 | $553.995400 | 1029% | Dec 2024 |
|
| Advisor Group Holdings | 129.00 | $453.576900 | 100% | Dec 2024 |
|
| Transce3nd | 127.00 | $444.995300 | 100% | Dec 2024 |
|
| Principal Securities | 32.00 | $112.000000 | 100% | Dec 2024 |
|
| Us Bancorp | 13.00 | $46.000500 | 0% | Dec 2024 |
|
| Coconut Grove Bank | 12.00 | $27.000000 | 100% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $9.999900 | -100% | Dec 2024 |
|
Who sold out of Mereo Biopharma Group Plc ads?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Fred Alger Management | Sep 2024 | 103k | $422k |
| GSA Capital Partners | Sep 2024 | 67k | $276k |
| PRIMECAP Management Company | Sep 2024 | 54k | $222k |
| Qube Research & Technologies | Sep 2024 | 50k | $204k |
| Advisors Preferred | Sep 2024 | 18k | $76k |
| Tower Research Capital | Sep 2024 | 645.00 | $2.7k |
| Cranbrook Wealth Management | Dec 2024 | 60.00 | $210.000000 |
| Barclays | Sep 2024 | 38.00 | $0 |